| 000 | 01748 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513230139.0 | ||
| 264 | 0 | _c20010201 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm000139k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, G R | |
| 245 | 0 | 0 |
_aA novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 2000 |
||
| 300 |
_a4964-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntramolecular Transferases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMicrosomes _xdrug effects |
| 650 | 0 | 4 |
_aPiperazines _xchemical synthesis |
| 650 | 0 | 4 |
_aPiperidines _xchemical synthesis |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 |
_aPyrimidines _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aHollinshead, D M | |
| 700 | 1 | _aStokes, E S | |
| 700 | 1 | _aWaterson, D | |
| 700 | 1 | _aClarke, D S | |
| 700 | 1 | _aFoubister, A J | |
| 700 | 1 | _aGlossop, S C | |
| 700 | 1 | _aMcTaggart, F | |
| 700 | 1 | _aMirrlees, D J | |
| 700 | 1 | _aSmith, G J | |
| 700 | 1 | _aWood, R | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 43 _gno. 26 _gp. 4964-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm000139k _zAvailable from publisher's website |
| 999 |
_c11089991 _d11089991 |
||